Emma Di Carlo Selected Research

Cytokines

1/2021	The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.
1/2018	Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.
1/2017	Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.
11/2014	The antitumor potential of Interleukin-27 in prostate cancer.
3/2014	IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation.
11/2010	Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells.
10/2010	Direct inhibition of human acute myeloid leukemia cell growth by IL-12.
10/2009	Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype.
7/2009	IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.
9/2006	Targeting tumor-related immunosuppression for cancer immunotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Di Carlo Research Topics

Disease

43	Neoplasms (Cancer) 02/2022 - 07/2002
10	Carcinoma (Carcinomatosis) 06/2006 - 01/2003
9	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2009
9	Carcinogenesis 01/2016 - 05/2003
6	Adenocarcinoma 01/2016 - 07/2002
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2003
5	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2004
2	Neuroblastoma 01/2017 - 05/2013
2	Lymphatic Metastasis 03/2016 - 10/2009
2	Inflammation (Inflammations) 08/2015 - 03/2014
2	Necrosis 02/2015 - 11/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2012 - 10/2010
2	Colitis 11/2007 - 04/2004
2	Glomerulonephritis 12/2005 - 11/2003
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2021
1	Fanconi Anemia (Fanconi's Anemia) 09/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Disease Progression 01/2016
1	Communicable Diseases (Infectious Diseases) 10/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2015
1	Adenoma (Adenomas) 08/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2015
1	Seroma 04/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Leukemia 03/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2010
1	Multiple Myeloma 08/2010
1	Lung Neoplasms (Lung Cancer) 10/2009
1	Adenocarcinoma of Lung 07/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2008
1	Plasmacytoma 08/2008
1	Lymphoma (Lymphomas) 08/2008

Drug/Important Bio-Agent (IBA)

17	Interleukin-12 (IL 12)IBA 10/2010 - 07/2002
16	CytokinesIBA 01/2021 - 07/2002
7	VaccinesIBA 07/2007 - 01/2003
6	Interleukin-6 (Interleukin 6)IBA 11/2016 - 12/2005
5	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 05/2003
5	InterleukinsIBA 01/2019 - 06/2004
5	Interleukin-27 (Interleukin 27)IBA 02/2015 - 08/2010
5	Proteins (Proteins, Gene)FDA Link 11/2008 - 04/2003
4	Interleukin-15 (Interleukin 15)IBA 01/2021 - 07/2002
4	AntigensIBA 07/2007 - 08/2003
3	LigandsIBA 01/2021 - 01/2003
3	ChemokinesIBA 01/2021 - 07/2002
3	PerforinIBA 01/2019 - 04/2003
3	Vascular Endothelial Growth Factor CIBA 01/2018 - 07/2009
3	Messenger RNA (mRNA)IBA 03/2016 - 10/2004
3	interleukin-21 (interleukin 21)IBA 09/2006 - 02/2004
3	DNA VaccinesIBA 06/2006 - 04/2004
3	Interferon-gamma (Interferon, gamma)IBA 12/2005 - 06/2003
3	AntibodiesIBA 02/2005 - 04/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 03/2016
2	CXC ChemokinesIBA 01/2021 - 02/2004
2	InterferonsIBA 01/2017 - 05/2013
2	AndrogensIBA 01/2016 - 03/2011
2	Peptides (Polypeptides)IBA 08/2015 - 04/2004
2	Antineoplastic Agents (Antineoplastics)IBA 11/2010 - 08/2010
2	Interleukin-8 (Interleukin 8)IBA 10/2010 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2004 - 07/2002
2	Immunoglobulin G (IgG)IBA 07/2003 - 05/2003
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2003 - 07/2002
1	8-hydroxyguanineIBA 09/2021
1	furanIBA 09/2021
1	Calcibiotic Root Canal SealerIBA 01/2021
1	TNF Receptor-Associated Factor 1IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	T-Cell Intracellular Antigen-1IBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Therapeutic UsesIBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Chromogranin AIBA 03/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	OsteopontinIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2015
1	AzoxymethaneIBA 08/2015
1	Dextrans (Dextran)FDA Link 08/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2014
1	Epithelial Cell Adhesion MoleculeIBA 01/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2014
1	Histocompatibility Antigens Class IIBA 05/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2013
1	Zoledronic Acid (Zometa)FDA Link 05/2013
1	Propidium (Propidium Iodide)IBA 03/2012
1	Bromodeoxyuridine (BrdU)IBA 03/2012
1	Annexin A5IBA 03/2012
1	Hormones (Hormone)IBA 03/2011
1	Interleukin-23 (Interleukin 23)IBA 11/2010
1	CD13 Antigens (Alanine Aminopeptidase)IBA 10/2010
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2009
1	Interleukin-7 (Interleukin 7)IBA 05/2009
1	IntegrinsIBA 11/2008
1	integrin beta5IBA 11/2008

Therapy/Procedure

5	Immunotherapy 01/2021 - 02/2006
4	Therapeutics 02/2015 - 10/2004
1	Intravenous Administration 01/2017
1	Prostatectomy (Retropubic Prostatectomy) 03/2011